Back to Search Start Over

Cross-Regional Data Initiative for the Assessment and Development of Treatment for Neurological and Mental Disorders

Authors :
Tsai,Daniel Hsiang-Te
Bell,J Simon
Abtahi,Shahab
Baak,Brenda
Bazelier,Marloes
Brauer,Ruth
Chan,Adrienne
Chan,Esther
Chen,Haoqian
Chui,Celine
Cook,Sharon
Crystal,Stephen
Gandhi,Poonam
Hartikainen,Sirpa
Ho,Frederick
Hsu,Shao-Ti
Ilomäki,Jenni
Kim,Ju Hwan
Klungel,Olaf
Koponen,Marjaana
Lau,Wallis
Lau,Kui
Lum,Terry
Luo,Hao
Man,Kenneth
Pell,Jill
Setoguchi,Soko
Shao,Shih-Chieh
Shen,Chin-Yao
Shin,Ju-Young
Souverein,Patrick
Tolppanen,Anna-Maija
Wei,Li
Wong,Ian
Lai,Edward Chia-Cheng
Tsai,Daniel Hsiang-Te
Bell,J Simon
Abtahi,Shahab
Baak,Brenda
Bazelier,Marloes
Brauer,Ruth
Chan,Adrienne
Chan,Esther
Chen,Haoqian
Chui,Celine
Cook,Sharon
Crystal,Stephen
Gandhi,Poonam
Hartikainen,Sirpa
Ho,Frederick
Hsu,Shao-Ti
Ilomäki,Jenni
Kim,Ju Hwan
Klungel,Olaf
Koponen,Marjaana
Lau,Wallis
Lau,Kui
Lum,Terry
Luo,Hao
Man,Kenneth
Pell,Jill
Setoguchi,Soko
Shao,Shih-Chieh
Shen,Chin-Yao
Shin,Ju-Young
Souverein,Patrick
Tolppanen,Anna-Maija
Wei,Li
Wong,Ian
Lai,Edward Chia-Cheng
Publication Year :
2023

Abstract

Daniel Hsiang-Te Tsai,1,2 J Simon Bell,3 Shahab Abtahi,4 Brenda N Baak,5 Marloes T Bazelier,4 Ruth Brauer,6 Adrienne YL Chan,6– 9 Esther W Chan,9– 12 Haoqian Chen,13 Celine SL Chui,9,14,15 Sharon Cook,16 Stephen Crystal,16 Poonam Gandhi,13 Sirpa Hartikainen,17 Frederick K Ho,18 Shao-Ti Hsu,1 Jenni Ilomäki,3 Ju Hwan Kim,19 Olaf H Klungel,4 Marjaana Koponen,17 Wallis CY Lau,6,8,9 Kui Kai Lau,20,21 Terry YS Lum,22 Hao Luo,22 Kenneth KC Man,6,8,9 Jill P Pell,18 Soko Setoguchi,13,23 Shih-Chieh Shao,1,24 Chin-Yao Shen,1 Ju-Young Shin,19,25,26 Patrick C Souverein,4 Anna-Maija Tolppanen,17 Li Wei,6,9 Ian CK Wong,6,8,9,27 Edward Chia-Cheng Lai1 1School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan; 2Centre for Neonatal and Paediatric Infection, St George’s University of London, London, UK; 3Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Australia; 4Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands; 5PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands; 6Research Department of Practice and Policy, UCL School of Pharmacy, London, UK; 7Groningen Research Institute of Pharmacy, Unit of Pharmacotherapy, ‐Epidemiology and ‐Economics, University of Groningen, Groningen, the Netherlands; 8Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, Special Administrative Region, People’s Republic of China; 9Laboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Hong Kong, Special Administrative Region, People’s Republic of China; 10Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, Special Administrative Region, Peopleâ

Details

Database :
OAIster
Notes :
text/html, English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1422111398
Document Type :
Electronic Resource